OR WAIT null SECS
May 15, 2023
Advanced continuous manufacturing with modular components is emerging as a preferred platform to produce APIs.
May 12, 2023
This approach is defined as being used to express transcription factor combinations to reprogram human induced pluripotent stem cells (iPSCs).
In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.
Congress have initiated a range of legislative proposals to further manage PBMs and the pharma market.
The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.
May 11, 2023
The objective of the partnership is to automate portions of ScaleReady’s CGT manufacturing workflow by using Cellular Origin’s robotic system for sterile liquid transfer.
EC has granted marketing authorization to Chiesi Global Rare Diseases and Protalix BioTherapeutics for PRX-102 (pegunigalsidase alfa).
Critical raw materials supplier, Biosynth, has acquired UK-based Cambridge Research Biochemicals (CRB).
Vetter is further expanding its production capacity and services at its Rankweil, Austria site.
May 10, 2023
The guidance is to provide information on compliance with applicable regulatory requirements and recommendations.